Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2010
Cash flows from operating activities:      
Net income $ 41,982 $ 67,936 $ 10,327
Reconciliation of net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 2,053 2,700 3,793
Stock-based compensation 1,205 1,021 1,529
Exchange (gain) loss 17 (52) (160)
Gain on sale of CNS assets (31,654)    
Gain on sale of ConferencePlus, net of tax (20,489)    
Loss on sale or disposal of fixed assets 18 2 19
Gain on sale of non-operating asset (325)    
Restructuring 1,217   609
Deferred taxes 12,438 (54,200)  
Changes in assets and liabilities:      
Accounts receivable 12,396 (6,426) 3,349
Inventory 1,852 3,702 (812)
Prepaid expenses and other current assets 1,002 1,132 3,249
Other assets (265) 167 815
Deferred revenue 336 (705) (1,630)
Accounts payable and accrued expenses (23,820) 8,522 (4,308)
Accrued compensation (2,919) 436 726
Net cash provided by (used in) operating activities (4,956) 24,235 17,506
Cash flows from investing activities:      
Maturities of held-to maturity short-term debt securities 8,352    
Maturities of other short-term investments 1,370 245  
Purchases of held-to-maturity short-term debt securities (16,746)    
Purchases of other short-term investments (6,941) (735)  
Purchases of property and equipment (819) (785) (948)
Proceeds from sale of a non-operating asset 325    
Proceeds from the sale of ConferencePlus, net of cash transferred 40,331      
Proceeds from sale of CNS assets 36,729    
Changes in restricted cash (7,451)    
Net cash provided by (used in) investing activities 55,150 (1,275) (948)
Cash flows from financing activities:      
Borrowing (repayment) of debt and leases payable     (43)
Purchases of treasury stock (17,385) (561) (1,429)
Excess tax benefits from stock-based compensation 145    
Proceeds from stock options exercised 1,684 2,616 4
Repurchase of subsidiary stock options (117) (36)  
Net cash provided by (used in) financing activities (15,673) 2,019 (1,468)
Effect of exchange rate changes on cash (97) 114 167
Net increase in cash 34,424 25,093 15,257
Cash and cash equivalents, beginning of period 86,408 [1] 61,315 46,058
Cash and cash equivalents, end of period 120,832 86,408 [1] 61,315
Supplemental disclosures of cash flow information:      
Cash paid for interest 0 1 7
Cash paid for income taxes, net $ 2,901 $ 874 $ 161
[1] The balance sheet as of March 31, 2011 includes the balances of ConferencePlus. As disclosed in Note 1, the Company completed the sale of ConferencePlus on December 31, 2011. See Note 1 for additional information.